CTSO's "Swiss Connection" to NVS and Car-T cell treatment became abundantly clear this week. I had wondered why that country had been chosen by CTSO for an EU office to serve Europe. Now it is obvious. Dr. June and NVS are based there. To your point Pears, CTSO needs a highly focused direction. Further research work and large scale trials involving Car-T treatment, propelled by NVS, could be it.
News 
Market Data 
Discover 
